Advances and issues in the pharmacotherapy of rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Clinical Pharmacy and Therapeutics

• Publication date

  1995-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2710.1995.tb00640.xPMID 7593375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methotrexate for Rheumatoid Arthritis

  1994cited by this paper
• Second-line drug therapy for rheumatoid arthritis.

  1994cited by this paper
• Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.

  1993cited by this paper
• Liver transplantation for patients with alcoholism and end-stage liver disease.

  1993cited by this paper
• Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1992cited by this paper
• Practice based evaluation of the longterm benefit of second line agents in rheumatoid arthritis.

  1992cited by this paper
• Arthritis in patients with psoriasis treated with gamma-interferon.

  1992cited by this paper
• Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going?

  1992cited by this paper
• Valuing Clinical Strategies Early in Their Development

  1992cited by this paper
• Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1992cited by this paper
• Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis.

  1992cited by this paper
• Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis

  1992cited by this paper
• A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?

  1992cited by this paper
• Valuing Clinical Strategies Early in Their Development

  1992cited by this paper
• Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going?

  1992cited by this paper
• Long-term second-line treatment: a prospective drug survival study.

  1992cited by this paper
• Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment.

  1991cited by this paper
• Long-term methotrexate therapy for rheumatoid arthritis.

  1991cited by this paper
• Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial.

  1991cited by this paper
• Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.

  1991cited by this paper
• Prognostic staging for therapy of rheumatoid arthritis.

  1991cited by this paper
• A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis.

  1991cited by this paper
• Safety issues related to DMARD therapy.

  1990cited by this paper
• Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis.

  1990cited by this paper
• Suppress rheumatoid inflammation early and leave the pyramid to the Egyptians.

  1990cited by this paper
• Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group.

  1990cited by this paper
• Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

  1990cited by this paper
• Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.

  1990cited by this paper
• Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis--lessons from Hodgkin's disease and coronary artery disease.

  1990cited by this paper
• Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy.

  1990cited by this paper
• Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.

  1990cited by this paper
• Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.

  1990cited by this paper
• Longterm experience with low dose weekly methotrexate in rheumatoid arthritis.

  1990cited by this paper
• Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.

  1990cited by this paper
• Winning the battle, losing the war? Another editorial about rheumatoid arthritis.

  1990cited by this paper
• Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.

  1990cited by this paper
• Rheumatoid arthritis. Pathophysiology and implications for therapy.

  1990cited by this paper
• The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis.

  1990cited by this paper
• Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis.

  1990cited by this paper
• Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritis

  1990cited by this paper
• Winning the battle, losing the war? Another editorial about rheumatoid arthritis.

  1990cited by this paper
• Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.

  1989cited by this paper
• Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment.

  1989cited by this paper
• Meta-analysis of injectable gold in rheumatoid arthritis.

  1989cited by this paper
• A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.

  1989cited by this paper
• Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial.

  1989cited by this paper
• Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study.

  1989cited by this paper
• Methotrexate-induced chronic liver injury: guidelines for detection and prevention. The ACG Committee on FDA-related matters. American College of Gastroenterology.

  1988cited by this paper
• Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.

  1988cited by this paper
• Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis.

  1987cited by this paper
• Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.

  1987cited by this paper
• Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.

  1987cited by this paper
• Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: a prospective study.

  1987cited by this paper
• Methotrexate in rheumatoid arthritis. Health and Public Policy Committee, American College of Physicians.

  1987cited by this paper
• Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis.

  1987cited by this paper
• Long-term outcome of treating rheumatoid arthritis: results after 20 years.

  1987cited by this paper
• Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.

  1987cited by this paper
• The work dynamics of the person with rheumatoid arthritis.

  1987cited by this paper
• Methotrexate in Rheumatoid Arthritis: Indications, Contraindications, Efficacy, and Safety

  1987cited by this paper
• Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study.

  1986cited by this paper
• A multicenter study of annual health service utilization and costs in rheumatoid arthritis.

  1986cited by this paper
• A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges.

  1986cited by this paper
• Impact of specific therapy upon rheumatoid arthritis.

  1986cited by this paper
• Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1985cited by this paper
• Remission in rheumatoid arthritis.

  1985cited by this paper
• Efficacy of low-dose methotrexate in rheumatoid arthritis.

  1985cited by this paper
• Practical results of treatment with disease-modifying antirheumatoid drugs.

  1985cited by this paper
• Methotrexate in rheumatoid arthritis.

  1985cited by this paper
• Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

  1985cited by this paper
• Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis.

  1984cited by this paper
• Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1983cited by this paper
• Does drug therapy slow radiographic deterioration in rheumatoid arthritis?

  1983cited by this paper
• Prognosis of inflammatory joint diseases. A three-year follow-up study.

  1983cited by this paper
• Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.

  1982cited by this paper
• Preliminary criteria for clinical remission in rheumatoid arthritis.

  1981cited by this paper
• Methotrexate induced liver cirrhosis

  1980cited by this paper
• The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs.

  1978cited by this paper
• Hepatotoxicity of long-term methotrexate therapy for psoriasis.

  1973cited by this paper
• Psoriasis-liver-methotrexate interactions.

  1973cited by this paper
• The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts.

  1972cited by this paper
• THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY: II. Effect of Aminopterin in Rheumatoid Arthritis and Psoriasis

  1951cited by this paper

• Family physician's perceptions of academic detailing for rheumatoid arthritis

  2012cites this paper
• Combination therapy for autoimmune diseases: the rheumatoid arthritis model

  2009cites this paper
• Combination Treatment in Autoimmune Diseases

  2002cites this paper